error

  • Could not retrieve the oEmbed resource.
Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

-

All research in progress seminars are off-the-record. Any information about methodology and/or results are embargoed until publication.

Abstract:

Current guidelines for economic evaluations of health interventions (cost-effectiveness or cost-benefit analyses) define relevant outcomes as those accruing to individuals receiving interventions. Little consensus exists on how to count health impacts of interventions that affect current and future fertility and childbearing. We sought to characterize current practices for counting such health outcomes. To do so, we developed a framework characterizing health interventions with direct and/or indirect effects on fertility and childbearing. We identified interventions that span the framework and performed a targeted literature review for economic evaluations of these interventions. For each article, we characterized how the potential health outcomes from each intervention were considered, focusing on QALYs associated with fertility and childbearing. This review of 108 economic evaluations led to striking insights about choices analysts make in the absence of clear guidance about how to include such QALYs. We will discuss these insights and their implications as well as the rationales on which they are based. In brief, economic evaluations inconsistently consider QALYs from current pregnancies and future fertility in ways that frequently appear biased. Given this, we believe that further guidance should be given by bodies like the Panel on Cost-Effectiveness in Health and Medicine to help to standardize practice and reporting in this important area.

CHP/PCOR Conference Room
117 Encina Commons, Room 119
Stanford, CA 94305

Encina Commons, Room 220
615 Crothers Way
Stanford, CA 94305-6006

(650) 721-2486 (650) 723-1919
0
Professor, Health Policy
jeremy-fisch_profile_compressed.jpg PhD

Jeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy, a Core Faculty Member at the Center for Health Policy and the Department of Health Policy, and a Faculty Affiliate of the Stanford Center on Longevity and Stanford Center for International Development. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011.

Past and current research topics:

  1. Type 2 diabetes and cardiovascular risk factors: Randomized and observational studies in Costa Rica examining the impact of community-based lifestyle interventions and the relationship of gender, risk factors, and care utilization.
  2. Cervical cancer: Model-based cost-effectiveness analyses and costing methods studies that examine policy issues relating to cervical cancer screening and human papillomavirus vaccination in countries including the United States, Brazil, India, Kenya, Peru, South Africa, Tanzania, and Thailand.
  3. Measles, haemophilus influenzae type b, and other childhood infectious diseases: Longitudinal regression analyses of country-level data from middle and upper income countries that examine the link between vaccination, sustained reductions in mortality, and evidence of herd immunity.
  4. Patient adherence: Studies in both developing and developed countries of the costs and effectiveness of measures to increase successful adherence. Adherence to cervical cancer screening as well as to disease management programs targeting depression and obesity is examined from both a decision-analytic and a behavioral economics perspective.
  5. Simulation modeling methods: Research examining model calibration and validation, the appropriate representation of uncertainty in projected outcomes, the use of models to examine plausible counterfactuals at the biological and epidemiological level, and the reflection of population and spatial heterogeneity.
CV
Speaker

Department of Management Science and Engineering
Stanford University
Huang Building, #262
Stanford, CA 94305-4026

(650) 725-1623 (650) 723-1614
0
Coleman F. Fung Professor of Engineering and Professor, by courtesy, of Health Policy
brandeau.jpg PhD

Margaret Brandeau is the Coleman F. Fung Professor in the School of Engineering at Stanford and a Professor of Medicine (by courtesy) at the Stanford University School of Medicine. Her research focuses on the development of applied mathematical and economic models to support health policy decisions.

She has published cost-effectiveness analyses of a variety of HIV and drug-abuse interventions including methadone maintenance, buprenorphine maintenance, HIV testing and counseling programs targeted to women of childbearing age, and HIV pre-exposure prophylaxis for key populations. She has also published a number of studies on effective allocation of HIV prevention resources. In addition, she co-edited the books Operations Research and Health Care: A Handbook of Methods and Applications (with Francois Sainfort and William Pierskalla, Kluwer Publishers, 2004) and Modeling the AIDS Epidemic: Planning, Policy, and Prediction (with Edward Kaplan, Raven Press, 1994). She has been a Principal Investigator and co-Principal Investigator on four sequential five-year NIDA-funded projects entitled "AIDS and Drug Abuse: Policy Modeling for Better Decisions" that have led to numerous publications and presentations. Recently she has also worked in the area of bioterrorism preparedness planning, and on hepatitis B prevention and control.

She is a Fellow of the Institute for Operations Research and Management Science (INFORMS) and a member of the Omega Rho International Honor Society for Operations Research and Management Science. From INFORMS she has received the President’s Award (recognizing important contributions to the welfare of society), the Pierskalla Prize (for research excellence in health care management science), the Philip McCord Morse Lectureship Award, and the Award for the Advancement of Women in Operations Research and the Management Sciences. She has also received the Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research from the International Society for Pharmacoeconomics and Outcomes Research, and a Presidential Young Investigator Award from the National Science Foundation, among other awards.  Professor Brandeau earned a BS in Mathematics and an MS in Operations Research from MIT, and a PhD in Engineering-Economic Systems from Stanford University.

Speaker
Seminars
-

All research in progress seminars are off-the-record. Any information about methodology and/or results are embargoed until publication.

Abstract:

One of the important benefits of an electronic medical record is the potential to provide targeted decision support and reminders for care. In addition to improving care these reminders serve a secondary purpose of documenting care that is now required for public reporting or pay for performance programs. Thus, there is pressure to add an ever increasing number of reminders with unclear consequences. I will review past studies using computerised reminders and present several randomized trials conducted or planned at the Palo Alto VA and Stanford hospitals. The goals of these reminders include increasing life-prolonging heart failure medications and device use, reducing inappropriate cardiac imaging, and rapid treatment for sepsis. Clinical reminders can be considered quality improvement and I will discuss the potential for conducting methodologically rigorous randomized reminder trials that are not "research".

CHP/PCOR Conference Room
117 Encina Commons, Room 119
Stanford, CA 94305

VA Palo Alto Medical Center
111C Cardiology
3801 Miranda Avenue
Palo Alto, CA 94304

(650) 493-5000 x64069 (650) 852-3473
0
Professor of Medicine (Cardiovascular) and Professor by courtesy of Health Research and Policy at the VA Palo Alto Health Care System
HeidenreichPaulprofile.jpeg MD, MS

Paul Heidenreich MD, MS is Professor and Vice-Chair for Clinical, Quality, and Analytics in the Department of Medicine. He also directs VA's Quality Enhancement Research Initiative (QUERI) in Medication Management and the Echocardiography Laboratory at the VA Palo Alto Health Care System. His research focuses on interventions to improve the quality of care for heart disease patients; the use of echocardiography to predict prognosis; the cost-effectiveness of new cardiovascular technologies; and outcomes research using existing clinical and administrative data. His administrative efforts focuses on measuring, improving, and disseminating the quality of care provided by faculty in the Department of Medicine.

Stanford Health Policy Associate
Speaker
Seminars
-

All research in progress seminars are off-the-record. Any information about methodology and/or results are embargoed until publication.

"Who Enrolls in Medicare Advantage? Evidence from the Health and Retirement Study"

CHP/PCOR Conference Room
117 Encina Commons, Room 119
Stanford, CA 94305

Kate Bundorf Speaker
Seminars
-

The United States healthcare system is a three trillion dollar enterprise, the largest in the developed world. Spending more than two to three times more money on healthcare, than the second leading country. When you consider that we are only the fifteenth healthiest country, it begs the question, are we getting our money's worth? This forum features two renowned experts who will discuss the causes and potential solutions to the extraordinary cost of American healthcare. Physician, journalist and Stanford alum Elisabeth Rosenthal has drawn national attention to the rising costs of U.S. health care through her widely-praised “Paying Till It Hurts” series in The New York Times. She will be joined by Professor Doug Owens, the Director of Stanford’s Center for Health Policy and an expert in health care cost-effectiveness research.

The Stanford Health Policy Forum is free and open to the public. For more information visit: http://healthpolicyforum.stanford.edu/.

Clark Center Auditorium 

Stanford, CA

Elisabeth Rosenthal Speaker

Encina Commons, Room 201 
615 Crothers Way Stanford, CA 94305-6006 

Executive Assistant: Soomin Li, soominli@stanford.edu
Phone: (650) 725-9911

(650) 723-0933 (650) 723-1919
0
Henry J. Kaiser, Jr. Professor
Professor, Health Policy
Senior Fellow, Freeman Spogli Institute for International Studies
Professor, Management Science & Engineering (by courtesy)
doug-headshot_tight.jpeg MD, MS

Douglas K. Owens is the Henry J. Kaiser, Jr. Professor, Chair of the Department of Health Policy in the Stanford University School of Medicine and Director of the Center for Health Policy (CHP) in the Freeman Spogli Institute for International Studies (FSI). He is a general internist, a Professor of Management Science and Engineering (by courtesy), at Stanford University; and a Senior Fellow at the Freeman Spogli Institute for International Studies.

Owens' research includes the application of decision theory to clinical and health policy problems; clinical decision making; methods for developing clinical guidelines; decision support; comparative effectiveness; modeling substance use and infectious diseases; cardiovascular disease; patient-centered decision making; assessing the value of health care services, including cost-effectiveness analysis; quality of care; and evidence synthesis.

Owens chaired the Clinical Guidelines Committee of the American College of Physicians for four years. The guideline committee develops clinical guidelines that are used widely and are published regularly in the Annals of Internal Medicine. He was a member and then Vice-Chair and Chair of the U.S. Preventive Services Task Force, which develops national guidelines on preventive care, including guidelines for screening for breast, colorectal, prostate, and lung cancer. He has helped lead the development of more than 50 national guidelines on treatment and prevention. He also was a member of the Second Panel on Cost Effectiveness in Health and Medicine, which developed guidelines for the conduct of cost-effectiveness analyses.

Owens also directed the Stanford-UCSF Evidence-based Practice Center. He co-directs the Stanford Health Services Research Program, and previously directed the VA Physician Fellowship in Health Services Research, and the VA Postdoctoral Informatics Fellowship Program.

Owens received a BS and an MS from Stanford University, and an MD from the University of California-San Francisco. He completed a residency in internal medicine at the University of Pennsylvania and a fellowship in health research and policy at Stanford. Owens is a past-President of the Society for Medical Decision Making. He received the VA Undersecretary’s Award for Outstanding Achievement in Health Services Research, and the Eisenberg Award for Leadership in Medical Decision Making from the Society for Medical Decision Making. Owens also received a MERIT award from the National Institutes on Drug Abuse to study HIV, HCV, and the opioid epidemic. He was elected to the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP.)

Chair, Department of Health Policy, School of Medicine
Director, Center for Health Policy, Freeman Spogli Institute for International Studies
CV
Date Label
Doug Owens Speaker
-

All research in progress seminars are off-the-record. Any information about methodology and/or results are embargoed until publication.

CHP/PCOR Conference Room

Encina Commons Room 210,
615 Crothers Way,
Stanford, CA 94305-6006

(650) 723-1919
0
Professor, Pediatrics
Professor, Health Policy
Professor, Epidemiology & Population Health (by courtesy)
sanders_photo_20153.jpg MD, MPH

Dr. Lee Sanders is a general pediatrician and Professor of Pediatrics at the Stanford University School of Medicine, where he is Chief of the Division of General Pediatrics. He holds a joint appointment in the Center for Health Policy in the Freeman Spogli Institute for International Studies, where he is a co-director of the Center for Policy, Outcomes and Prevention (CPOP).

An author of numerous peer-reviewed articles addressing child health disparities, Dr. Sanders is a nationally recognized scholar in the fields of health literacy and child chronic-illness care.  Dr. Sanders was named a Robert Wood Johnson Foundation Generalist Physician Faculty Scholar for his leadership on the role of maternal health literacy and English-language proficiency in addressing child health disparities.  Aiming to make the US health system more navigable for the one in 4 families with limited health literacy, he has served as an advisor to the Institute of Medicine, the Centers for Disease Control and Prevention, the Food and Drug Administration, the American Academy of Pediatrics, the Academic Pediatric Association, and the American Cancer Society.  Dr. Sanders leads a multi-disciplinary CPOP research team that provides analytic guidance to national and state policies affecting children with complex chronic illness – with a focus on the special health-system requirements that arise from the unique epidemiology, care-use patterns, and health-care costs for this population.  He leads another CPOP/PCOR-based research team that applies family-centered approaches to new technologies that aim to improve care coordination for children with medical complexity.    Dr. Sanders is also principal investigator on two NIH-funded studies that address health literacy in the pediatric context: one aims to assess the efficacy of a low-literacy, early-childhood intervention designed to prevent early childhood obesity; the other aims to provide the FDA with guidance on improved labeling of pediatric liquid medication.  Research settings for this work include state and regional health departments, primary-care and subspecialty-care clinics, community-health centers, WIC offices, federally subsidized child-care centers, and family advocacy centers.

Dr. Sanders received a BA in History and Science from Harvard University, an MD from Stanford University, and a MPH from the University of California, Berkeley.  Between 2006 and 2011, Dr. Sanders served as Medical Director of Children’s Medical Services South Florida, a Florida state agency that coordinates care for more than 10,000 low-income children with special health care needs.  He was also Medical Director for Reach Out and Read Florida, a pediatric-clinic-based program that provides books and early-literacy promotion to more than 200,000 underserved children.  At the University of Miami, Dr. Sanders directed the Jay Weiss Center for Social Medicine and Health Equity, which fosters a scholarly community committed to addressing global health inequities through community-based participatory research.  At Stanford University, Dr. Sanders served as co-medical director of the Family Advocacy Program, which provides free legal assistance to help address social determinants of child health.

Fluent in Spanish, Dr. Sanders is co-director of the Complex Primary Care Clinic at Stanford Children’s Health, which provides multi-disciplinary team care for children with complex chronic conditions.  Dr. Sanders is also the father of two daughters, aged 11 and 14 years, who make sure he practices talking less and listening more.

Co-Director, Center for Policy, Outcomes & Prevention (CPOP)
Chief, Division of General Pediatrics, School of Medicine
CV
Date Label
Lee Sanders Speaker

VA Palo Alto Health Care System Medical Service (111) 3801 Miranda Avenue Palo Alto, CA 94304;

Encina Commons, 615 Crothers Way Room 210, Stanford, CA 94305-6006

(650) 493-5000,,1,,1,62105
0
Professor, Health Policy
Professor, Medicine (by courtesy)
mary_goldstein_profile.jpg MD, MS

 

Mary K. Goldstein is a Professor of Health Policy and a core faculty member at the Department of Health Policy and the Center for Health Policy, and the Director of the Geriatrics Research Education and Clinical Center (GRECC) at the VA Palo Alto Health Care System. She directs the Primary Care Policy and Practice Advancement program at PCOR, the Stanford/VA Palo Alto Geriatric Medicine Fellowship Program, and the Special Fellowship Program in Advanced Geriatrics at VA Palo Alto. She also serves as associate director for the Physician Post-Residency Fellowship Program in Health Services Research and Development, and for the Postdoctoral Fellowship in Medical Informatics, both at VA Palo Alto Health Care System.

Goldstein studies innovative methods of implementing evidence-based clinical practice guidelines for quality improvement. She leads the ATHENA Decision Support System project that has developed and implemented an automated clinical decision support system for primary care clinicians, using hypertension as a model, and now extended into several other clinical domains.  Goldstein's research also explores older adults' health preferences (health utility) for application to cost-effectiveness analysis.

Goldstein is a fellow of the American Geriatrics Society, and an emerita of the Society's board of directors. Goldstein has received a number of honors and awards including an Advanced Career Development award from the Department of Veterans Affairs Health Services Research and Development (HSR&D) program.  She received a BA in philosophy and an MD, both from Columbia University, and completed her residency in family medicine at Duke University Medical Center. At the Stanford School of Medicine she completed an AHRQ-funded fellowship and an MS in health services research.

CV
Mary Goldstein Speaker
Seminars
Paragraphs

In response to the current outbreak, the international community has endorsed the clinical use of unregistered treatments for Ebola. Even with this accelerated pathway to in-human testing and use, radically novel approaches to drug development will be needed to improve the likelihood that a treatment is realised. Bypassing steps in development does not alter the probability of success, and historical patterns in drug development suggest that there is a slim probability of success with the current portfolio of potential Ebola treatments (all of which are were in preclinical development prior to the outbreak)....

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
The Lancet Global Health
Authors
News Type
News
Date
Paragraphs

The Ebola epidemic, which could affect hundreds of thousands of West Africans, can only be contained by rebuilding public trust and local health systems decimated by years of neglect, according to a panel convened by the Freeman Spogli Institute for International Studies and Stanford Medicine. FSI Senior Fellows David RelmanPaul WiseStephen Stedman, Michele Barry and Douglas Owens were among the panelists.

The World Health Organization estimates 2,811 people have died of the virus since the outbreak began earlier this year and that 5,864 people currently are infected in Sierra Leone, Liberia, Guinea, Senegal and Nigeria.

In this Stanford Medicine news story, Owens, a professor of medicine and director of the Center for Health Policy at FSI, cites a new report by the Centers for Disease Control and Prevention that estimates that even with "very aggressive" intervention, there would be at least 25,000 cases by late December. If intervention is delayed by just one month, the CDC estimates there would be 3,000 new cases every day; if it's delayed by two months, there will be 10,000 new cases daily. "It gives you a sense of the extraordinary urgency in terms of time," Owens told the audience.

Relman and CISAC biosecurity fellow Megan Palmer have also done a Q&A about the virus.

And you can listen to a KQED Public Radio talk show about Ebola that included Relman. 

 

 

 

 

Hero Image
ebola woman
A pregnant woman suspected of contracting Ebola is lifted by stretcher into an ambulance in Freetown, Sierra Leone, Sept. 19, 2014 in a handout photo provided by UNICEF.
UNICEF/Reuters
All News button
1
-

No RSVP necessary for this public event.

Panelists

Michele Barry, MD: Medicine and Tropical Diseases; Center for Innovation in Global Health

Doug Owens, MD: Medicine; Center for Health Policy/Primary Care Outcomes Research

David Relman, MD: Medicine, Microbiology & Immunology; Center for International Security and Cooperation

Stephen J. Stedman: Center on Democracy, Development and the Rule of Law

Paul Wise, MD: Pediatrics; Center for Health Policy/Primary Care Outcomes Research

 

Co-sponsors:

Freeman Spogli Institute for International Studies

Stanford University School of Medicine

Center for African Studies

Center for Health Policy/Center for Primary Care and Outcomes Research

Center for Innovation in Global Health

Center for International Security and Cooperation

Center on Democracy, Development, and the Rule of Law

McCoy Family Center for Ethics in Society

Bechtel Conference Center

Encina Hall

Michele Barry Panelist

Encina Commons, Room 201 
615 Crothers Way Stanford, CA 94305-6006 

Executive Assistant: Soomin Li, soominli@stanford.edu
Phone: (650) 725-9911

(650) 723-0933 (650) 723-1919
0
Henry J. Kaiser, Jr. Professor
Professor, Health Policy
Senior Fellow, Freeman Spogli Institute for International Studies
Professor, Management Science & Engineering (by courtesy)
doug-headshot_tight.jpeg MD, MS

Douglas K. Owens is the Henry J. Kaiser, Jr. Professor, Chair of the Department of Health Policy in the Stanford University School of Medicine and Director of the Center for Health Policy (CHP) in the Freeman Spogli Institute for International Studies (FSI). He is a general internist, a Professor of Management Science and Engineering (by courtesy), at Stanford University; and a Senior Fellow at the Freeman Spogli Institute for International Studies.

Owens' research includes the application of decision theory to clinical and health policy problems; clinical decision making; methods for developing clinical guidelines; decision support; comparative effectiveness; modeling substance use and infectious diseases; cardiovascular disease; patient-centered decision making; assessing the value of health care services, including cost-effectiveness analysis; quality of care; and evidence synthesis.

Owens chaired the Clinical Guidelines Committee of the American College of Physicians for four years. The guideline committee develops clinical guidelines that are used widely and are published regularly in the Annals of Internal Medicine. He was a member and then Vice-Chair and Chair of the U.S. Preventive Services Task Force, which develops national guidelines on preventive care, including guidelines for screening for breast, colorectal, prostate, and lung cancer. He has helped lead the development of more than 50 national guidelines on treatment and prevention. He also was a member of the Second Panel on Cost Effectiveness in Health and Medicine, which developed guidelines for the conduct of cost-effectiveness analyses.

Owens also directed the Stanford-UCSF Evidence-based Practice Center. He co-directs the Stanford Health Services Research Program, and previously directed the VA Physician Fellowship in Health Services Research, and the VA Postdoctoral Informatics Fellowship Program.

Owens received a BS and an MS from Stanford University, and an MD from the University of California-San Francisco. He completed a residency in internal medicine at the University of Pennsylvania and a fellowship in health research and policy at Stanford. Owens is a past-President of the Society for Medical Decision Making. He received the VA Undersecretary’s Award for Outstanding Achievement in Health Services Research, and the Eisenberg Award for Leadership in Medical Decision Making from the Society for Medical Decision Making. Owens also received a MERIT award from the National Institutes on Drug Abuse to study HIV, HCV, and the opioid epidemic. He was elected to the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP.)

Chair, Department of Health Policy, School of Medicine
Director, Center for Health Policy, Freeman Spogli Institute for International Studies
CV
Date Label
Doug Owens Panelist

CISAC
Stanford University
Encina Hall, E209
Stanford, CA 94305-6165

0
Senior Fellow at the Freeman Spogli Institute for International Studies
Thomas C. and Joan M. Merigan Professor
Professor of Medicine
Professor of Microbiology and Immunology
1-RSD13_085_0052a-001.jpg MD

David A. Relman, M.D., is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine, and of Microbiology and Immunology at Stanford University, and Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. He is also Senior Fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford, and served as science co-director at the Center for International Security and Cooperation at Stanford from 2013-2017. He is currently director of a new Biosecurity Initiative at FSI.

Relman was an early pioneer in the modern study of the human indigenous microbiota. Most recently, his work has focused on human microbial community assembly, and community stability and resilience in the face of disturbance. Ecological theory and predictions are tested in clinical studies with multiple approaches for characterizing the human microbiome. Previous work included the development of molecular methods for identifying novel microbial pathogens, and the subsequent identification of several historically important microbial disease agents. One of his papers was selected as “one of the 50 most important publications of the past century” by the American Society for Microbiology.

Dr. Relman received an S.B. (Biology) from MIT, M.D. from Harvard Medical School, and joined the faculty at Stanford in 1994. He served as vice-chair of the NAS Committee that reviewed the science performed as part of the FBI investigation of the 2001 Anthrax Letters, as a member of the National Science Advisory Board on Biosecurity, and as President of the Infectious Diseases Society of America. He is currently a member of the Intelligence Community Studies Board and the Committee on Science, Technology and the Law, both at the National Academies of Science. He has received an NIH Pioneer Award, an NIH Transformative Research Award, and was elected a member of the National Academy of Medicine in 2011.

Stanford Health Policy Affiliate
CV
David Relman Panelist
Stephen J. Stedman Panelist
0
Richard E. Behrman Professor of Child Health and Society
Senior Fellow, Freeman Spogli Institute for International Studies
rsd15_081_0253a.jpg MD, MPH

Dr. Paul Wise is dedicated to bridging the fields of child health equity, public policy, and international security studies. He is the Richard E. Behrman Professor of Child Health and Society and Professor of Pediatrics, Division of Neonatology and Developmental Medicine, and Health Policy at Stanford University. He is also co-Director, Stanford Center for Prematurity Research and a Senior Fellow in the Center on Democracy, Development, and the Rule of Law, and the Center for International Security and Cooperation, Freeman Spogli Institute for International Studies, Stanford University. Wise is a fellow of the American Academy of Arts and Sciences and has been working as the Juvenile Care Monitor for the U.S. Federal Court overseeing the treatment of migrant children in U.S. border detention facilities.

Wise received his A.B. degree summa cum laude in Latin American Studies and his M.D. degree from Cornell University, a Master of Public Health degree from the Harvard School of Public Health and did his pediatric training at the Children’s Hospital in Boston. His former positions include Director of Emergency and Primary Care Services at Boston Children’s Hospital, Director of the Harvard Institute for Reproductive and Child Health, Vice-Chief of the Division of Social Medicine and Health Inequalities at the Brigham and Women’s Hospital and Harvard Medical School and was the founding Director or the Center for Policy, Outcomes and Prevention, Stanford University School of Medicine. He has served in a variety of professional and consultative roles, including Special Assistant to the U.S. Surgeon General, Chair of the Steering Committee of the NIH Global Network for Women’s and Children’s Health Research, Chair of the Strategic Planning Task Force of the Secretary’s Committee on Genetics, Health and Society, a member of the Advisory Council of the National Institute of Child Health and Human Development, NIH, and the Health and Human Secretary’s Advisory Committee on Infant and Maternal Mortality.

Wise’s most recent U.S.-focused work has addressed disparities in birth outcomes, regionalized specialty care for children, and Medicaid. His international work has focused on women’s and child health in violent and politically complex environments, including Ukraine, Gaza, Central America, Venezuela, and children in detention on the U.S.-Mexico border.  

Core Faculty, Center on Democracy, Development and the Rule of Law
Affiliated faculty at the Center for International Security and Cooperation
Date Label
Paul Wise Panelist
Panel Discussions
Paragraphs

Since economic liberalization in the late 1970s, China’s health care providers have grown heavily reliant on revenue from drugs, which they both prescribe and sell. To curb abuse and to promote the availability, safety, and appropriate use of essential drugs, China introduced its national essential drug list in 2009 and implemented a zero markup policy designed to decouple provider compensation from drug prescription and sales. We collected and analyzed representative data from China’s township health centers and their catchment-area populations both before and after the reform. We found large reductions in drug revenue, as intended by policy makers. However, we also found a doubling of inpatient care that appeared to be driven by supply, instead of demand. Thus, the reform had an important unintended consequence: China’s health care providers have sought new, potentially inappropriate, forms of revenue.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Health Affairs
Authors
Grant Miller
Subscribe to Health and Medicine